DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Befetupitant
Befetupitant
PHARMACEUTICAL APPENDIX to the TARIFF SCHEDULE 2 Table 1
Compositions for Treating Centrally Mediated
( 12 ) United States Patent
Modifications to the Harmonized Tariff Schedule of the United States To
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Lääkeaineiden Yleisnimet (INN-Nimet) 21.6.2021
Neurokinin Receptor NK Receptor
(12) Patent Application Publication (10) Pub. No.: US 2014/0194395 A1 TRENTO Et Al
Stembook 2018.Pdf
A Abacavir Abacavirum Abakaviiri Abagovomab Abagovomabum
PHARMACEUTICAL APPENDIX to the HARMONIZED TARIFF SCHEDULE Harmonized Tariff Schedule of the United States (2011) (Rev
Patent Application Publication ( 10 ) Pub . No . : US 2019 / 0231688 A1
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Sanofi-Aventis Needs Successes, Not Failures
WO 2017/152062 Al 8 September 2017 (08.09.2017) P O P C T
Neurokinin Receptor NK Receptor
Ep 2114130 B1
O-Ribose Methyltransferase Nsp16 of SARS-Cov-2
Top View
Compositions for Treating Centrally Mediated Nausea and Vomiting
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
Modulating Ocular Surface Pain Through Neurokinin-1 Receptor Blockade
Neurokinin-1 Receptor-Based Bivalent Drugs in Pain Management: the Journey to Nowhere?